JNJ vs VNT · P/E 17, rev $49.37B vs P/E 10, rev $1.51B
Johnson & Johnson (JNJ) versus Vontier Corp (VNT) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Vontier Corp (VNT) is a scientific & technical instruments company listed on NYSE.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported VNT revenue for 2026-07-03 was $1.51B. Net income was $121.7M. VNT currently screens at market cap $4.09B and trailing P/E 10.3.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. VNT currently screens at market cap $4.09B and trailing P/E 10.3.
Not investment advice. Open the JNJ and VNT stock pages for the full models.
Not investment advice.